全文获取类型
收费全文 | 116158篇 |
免费 | 11258篇 |
国内免费 | 5229篇 |
专业分类
耳鼻咽喉 | 2472篇 |
儿科学 | 739篇 |
妇产科学 | 2072篇 |
基础医学 | 11940篇 |
口腔科学 | 11872篇 |
临床医学 | 8193篇 |
内科学 | 13895篇 |
皮肤病学 | 2455篇 |
神经病学 | 573篇 |
特种医学 | 4438篇 |
外国民族医学 | 123篇 |
外科学 | 14792篇 |
综合类 | 18306篇 |
现状与发展 | 25篇 |
预防医学 | 3308篇 |
眼科学 | 486篇 |
药学 | 7981篇 |
41篇 | |
中国医学 | 2359篇 |
肿瘤学 | 26575篇 |
出版年
2024年 | 227篇 |
2023年 | 1835篇 |
2022年 | 3382篇 |
2021年 | 4580篇 |
2020年 | 4250篇 |
2019年 | 4056篇 |
2018年 | 3874篇 |
2017年 | 4199篇 |
2016年 | 4624篇 |
2015年 | 5109篇 |
2014年 | 7460篇 |
2013年 | 7253篇 |
2012年 | 6743篇 |
2011年 | 7266篇 |
2010年 | 5824篇 |
2009年 | 5782篇 |
2008年 | 5923篇 |
2007年 | 6150篇 |
2006年 | 5709篇 |
2005年 | 5213篇 |
2004年 | 4197篇 |
2003年 | 3732篇 |
2002年 | 3190篇 |
2001年 | 3016篇 |
2000年 | 2564篇 |
1999年 | 2060篇 |
1998年 | 1881篇 |
1997年 | 1760篇 |
1996年 | 1508篇 |
1995年 | 1303篇 |
1994年 | 1195篇 |
1993年 | 853篇 |
1992年 | 805篇 |
1991年 | 658篇 |
1990年 | 580篇 |
1989年 | 536篇 |
1988年 | 481篇 |
1987年 | 399篇 |
1986年 | 336篇 |
1985年 | 350篇 |
1984年 | 298篇 |
1983年 | 222篇 |
1982年 | 247篇 |
1981年 | 223篇 |
1980年 | 198篇 |
1979年 | 150篇 |
1978年 | 114篇 |
1977年 | 117篇 |
1976年 | 87篇 |
1975年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
《Cancer cell》2021,39(11):1497-1518.e11
12.
13.
Is it possible to make a diagnosis of raw,heated, and baked egg allergy in children using cutoffs? A systematic review 下载免费PDF全文
14.
15.
Bimal Bhindi Christine M. Lohse Phillip J. Schulte Ross J. Mason John C. Cheville Stephen A. Boorjian Bradley C. Leibovich R. Houston Thompson 《European urology》2019,75(5):766-772
Background
Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.Objective
To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.Design, setting, and participants
In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.Intervention
RN and PN.Outcome measurements and statistical analysis
Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal , which ranges from 0 to 1, with higher values indicating increased predictive ability.Results and limitations
The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal ). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal ). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.Conclusions
We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.Patient summary
We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors. 相似文献16.
Lara Feulner Hamed S. Najafabadi Simon Tanguay Janusz Rak Yasser Riazalhosseini 《Urologic oncology》2019,37(2):166-175
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献17.
目的:肌少症对老年肝癌术后恢复及预后的影响。方法:选取2015年1月至2017年12月收治的114例老年肝癌,根据有无合并肌少症,分为肌少症组(n=35)和非肌少症组(n=79)。比较两组患者的术后恢复及生存情况。结果:肌少症组总并发症发生率、住院时间和30 d再入院率均高于对照组,差异均有统计学意义(P<0.05)。肌少症组中位生存时间为25.9个月,1年、2年、3年累积总生存率为74.3%、51.1%、24.5%,而非肌少症组中位生存时间为35.7个月,1年、2年、3年累积总生存率为87.3%、75.6%、49.4%,差异有统计学意义(P=0.004)。单因素分析结果显示,老年肝癌术后预后与Charlson合并症指数(CCI)、肌少症、巴塞罗那分期(BCLC)、甲胎蛋白、肿瘤大小、肿瘤个数、肿瘤分化程度、微血管侵犯(MVI)相关(P<0.05)。Cox多因素分析结果显示,CCI、肌少症、BCLC分期、肿瘤个数、MVI是老年肝癌术后预后的独立危险因素(P<0.05)。结论:肌少症会增加老年肝癌患者术后并发症发生率,延长住院时间,影响术后恢复,同时也会降低总生存率。 相似文献
18.
19.
Background and aimPatient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects and/or burden of different treatment options. However, often uncertainty exists around the probability estimates for recurrence/survival and side-effects which is too relevant to be ignored. Evidence is lacking on the best way to communicate these uncertainties. The aim of this study is to develop a method to incorporate uncertainties in a patient decision aid for breast cancer patients to support their decision on radiotherapy.MethodsFirstly, qualitative interviews were held with patients and health care professionals. Secondly, in the development phase, thinking aloud sessions were organized with four patients and 12 health care professionals, individual and group-wise.ResultsConsensus was reached on a pictograph illustrating the whole range of uncertainty for local recurrence risks, in combination with textual explanation that a more exact personalized risk would be given by their own physician. The pictograph consisted of 100 female icons in a 10 x 10 array. Icons with a stepwise gradient color indicated the uncertainty margin. The prevalence and severity of possible side-effects were explained using verbal labels.ConclusionsWe developed a novel way of visualizing uncertainties in recurrence rates in a patient decision aid. The effect of this way of communicating risk uncertainty is currently being tested in the BRASA study (NCT03375801). 相似文献
20.
《Surgical pathology clinics》2015,8(4):587-621
According to the current World Health Organization (WHO), renal cell carcinomas (RCCs) that primarily affect adults are classified into 8 major subtypes. Additional emerging entities in renal neoplasia have also been recently recognized and these are discussed in further detail by Mehra et al (Emerging Entities in Renal Neoplasia, Surgical Pathology Clinics, 2015, Volume 8, Issue 4). In most cases, the diagnosis of a RCC subtype can be based on morphologic criteria, but in some circumstances the use of ancillary studies can aid in the diagnosis. This review discusses the morphologic, genetic, and molecular findings in RCCs previously recognized by the WHO, and provides clues to distinction from each other and some of the newer subtypes of RCC. As prognosis and therapeutic options vary for the different subtypes of RCC, accurate pathologic distinction is critical for patient care. 相似文献